Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neuronetics (STIM) Accumulated Expenses (2017 - 2025)

Neuronetics (STIM) has disclosed Accumulated Expenses for 9 consecutive years, with $12.3 million as the latest value for Q4 2025.

  • Quarterly Accumulated Expenses rose 5208.62% to $12.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $12.3 million through Dec 2025, up 5208.62% year-over-year, with the annual reading at $12.3 million for FY2025, 5208.62% up from the prior year.
  • Accumulated Expenses for Q4 2025 was $12.3 million at Neuronetics, up from $169000.0 in the prior quarter.
  • The five-year high for Accumulated Expenses was $12.3 million in Q4 2025, with the low at $169000.0 in Q3 2025.
  • Average Accumulated Expenses over 5 years is $3.3 million, with a median of $395500.0 recorded in 2021.
  • Peak annual rise in Accumulated Expenses hit 5208.62% in 2025, while the deepest fall reached 98.52% in 2025.
  • Over 5 years, Accumulated Expenses stood at $306000.0 in 2021, then skyrocketed by 33.99% to $410000.0 in 2022, then crashed by 48.05% to $213000.0 in 2023, then increased by 8.92% to $232000.0 in 2024, then skyrocketed by 5208.62% to $12.3 million in 2025.
  • According to Business Quant data, Accumulated Expenses over the past three periods came in at $12.3 million, $169000.0, and $7.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.